Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insufficient Physical Activity”

93 trials

Showing 20 of 93 results

Not applicableLooking for participantsNCT07223112
What this trial is testing

Effectiveness of Interventions to Promote Physical Activity During Pregnancy

Who this might be right for
PregnancySedentary BehaviorInsufficient Physical Activity
University of Central Florida 60
Large-scale testing (Phase 3)Study completedNCT00837577
What this trial is testing

MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC 133
Large-scale testing (Phase 3)Study completedNCT00411554
What this trial is testing

Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC 319
Not applicableUnknownNCT05632718
What this trial is testing

Is Resistance Exercise More Effective Than Endurance in Reducing Obesity Relapse in Post-bariatric Surgery Patients

Who this might be right for
Bariatric Surgery Patients
Universidade do Porto 100
Large-scale testing (Phase 3)Study completedNCT01587989
What this trial is testing

RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 77
Large-scale testing (Phase 3)Study completedNCT01809327
What this trial is testing

Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 1,186
Large-scale testing (Phase 3)UnknownNCT03159052
What this trial is testing

Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd. 450
Large-scale testing (Phase 3)Study completedNCT02121717
What this trial is testing

Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 535
Post-approval studies (Phase 4)Study completedNCT01399697
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 261
Large-scale testing (Phase 3)Study completedNCT02173457
What this trial is testing

Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 740
Large-scale testing (Phase 3)Study completedNCT02577016
What this trial is testing

Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 141
Large-scale testing (Phase 3)Study completedNCT00528372
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,067
Large-scale testing (Phase 3)Study completedNCT01091675
What this trial is testing

Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs

Who this might be right for
Ankylosing Spondylitis
Spanish Foundation of Rheumatology 58
Post-approval studies (Phase 4)Study completedNCT01686711
What this trial is testing

A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322

Who this might be right for
Diabetes Mellitus
Takeda 207
Large-scale testing (Phase 3)Study completedNCT01177384
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 380
Large-scale testing (Phase 3)Study completedNCT02068443
What this trial is testing

Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 374
Large-scale testing (Phase 3)Study completedNCT01177813
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 986
Not applicableStudy completedNCT01388309
What this trial is testing

An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 64
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Large-scale testing (Phase 3)Study completedNCT01431807
What this trial is testing

Long-term Study of SYR-472

Who this might be right for
Diabetes Mellitus
Takeda 680
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation